Celyxa, Inc.

Leadership

Decades of hands-on clinical data and technology leadership, brought together to build solutions sponsors can trust.

Dr. Purushottam Surti

Dr. Purushottam Surti

Principal - Solutions and Services

Dr Puru Surti is a medical professional with over 20 years of leadership experience in clinical development, data management, and AI solutions.

He leads the development of AI-powered solutions, with a strong foundation of real data. That enables him to transform clinical data into intelligent automation, actionable insights, and interactive visualizations across the drug development lifecycle.

His focus is on delivering innovative technologies to provide clinical development sponsors efficient and smarter solutions.

Vikas Solegaonkar

Vikas Solegaonkar

Principal - Technology

Vikas, a graduate of the Indian Institute of Technology (IIT) Bombay, is a seasoned technology architect with over 20 years of experience delivering secure, scalable enterprise solutions.

He specializes in cloud architecture, Generative AI, and Data Visualization, he enables accelerated transformation through innovative technology.

With passion to solve complex challenges, he designs smart, future-ready solutions that drive business growth and operational excellence. Vikas leads technology architecture providing innovative solutions to clinical development sponsors.

Why us?

A company with team professionals in clinicals strategy, design, operations, biostatistics, data management and regulatory submissions of drugs, devices and diagnostic agents.

How we can help?

We can support designing and executing clinical trials for trial sponsors of any size — from biotech startups to big pharmaceuticals — tailored to the requirements of the sponsor.

Experience the difference

  • End to end clinical strategy, development and trial solutions and services
  • Work with big, medium or small companies but specializes in working with small and medium sized companies
  • Expertise in oncology, neurology, metabolic diseases, rare and orphan diseases
  • Led or involved in at least 10 NDAs, BLAs, INDs, PMAs
  • Experience with FDA advisory committees, preparation, presentation, and discussion
Therapeutic focus

Deep expertise across complex indications

Our team has led or contributed to programs spanning a broad range of therapeutic areas and regulatory pathways.

Therapeutic Areas

  • Oncology
  • Neurology
  • Metabolic diseases
  • Rare and orphan diseases
  • Chardiovascular
  • Immunology

Regulatory Submissions

  • NDAs — New Drug Applications
  • BLAs — Biologics License Applications
  • INDs — Investigational New Drug applications
  • PMAs — Premarket Approval applications

Who We Serve

  • Biotech startups
  • Small and medium sized companies
  • Big pharmaceuticals
  • Device and diagnostic sponsors
Work with us